United States News Todas as matérias

General Motors (NYSE:GM) and Lockheed Martin (NYSE:LMT) launched a partnership to expand U.S. defense production capacity.

Innoviva (NASDAQ:INVA) partnered with Dr. Reddy’s Laboratories (NYSE:RDY) to commercialize antibiotic XACDURO across four international territories.

One Stop Systems (NASDAQ:OSS) announced an initial $8.4 million defense contract to supply high-performance computing servers.

Yum! Brands (NYSE:YUM) executed definitive agreements to sell its Pizza Hut restaurant brand for $2.7 billion in the aggregate.

Allergan Aesthetics (NYSE:ABBV) received U.S. FDA approval for SKINVIVE neck treatments as its second product indication.

Swvl Holdings (NASDAQ:SWVL) announced its financial results for the three months ended March 31, 2026, revealing a substantial 68% year-over-year increase in total revenue to $8.2M.

Clinical-stage biotech company Clearmind Medicine (NASDAQ:CMND) has successfully completed the dosing of all 24 healthy participants in Part A of its FDA-regulated Phase I/II trial evaluating its proprietary compound, CMND-100, for the treatment of Alcohol Use Disorder.

Solana Company (NASDAQ:HSDT) rejected an unsolicited all-stock acquisition proposal from Forward Industries (NASDAQ:FWDI) valuing the business at $1.48 per share.

Clinical-stage biopharmaceutical firm HCW Biologics (NASDAQ:HCWB) reported positive preliminary human data from its Phase 1 trial of HCW9302, revealing that all three mild alopecia areata patients in the 3 μg/kg cohort achieved a 25% or greater reduction in SALT scores.

NovaBridge Biosciences (NASDAQ:NBP) received FDA Fast Track Designation for its bispecific antibody givastomig to treat advanced gastric adenocarcinoma expressing Claudin 18.2 protein levels.

Trinity Biotech (NASDAQ:TRIB) secured new purchase orders for over 2 million HIV tests to support its annual financial objectives.

Zai Lab (NASDAQ:ZLAB) has received European orphan drug designation for its antibody-drug conjugate targeting 375,000 annual lung cancer cases.

Nebius (NASDAQ:NBIS) completed its corporate acquisition of model optimization developer Eigen AI on June 10, 2026.

Vince Holding (NASDAQ:VNCE) reported a 10.5% increase in first-quarter net sales to $64 million, driven by expansion across its direct-to-consumer and wholesale segments.

Edgewise Therapeutics (NASDAQ:EWTX) reported positive 12-week Phase 2 data evaluating its investigational heart disease treatment called EDG-7500.

Invivyd (NASDAQ:IVVD) completed enrollment in its Phase 3 LIBERTY trial to evaluate a potential COVID-19 prevention option.

Robinhood Markets (NASDAQ:HOOD) announced a 10% workforce reduction to maintain its long-term corporate agility and efficiency.

Prestige Consumer Healthcare (NYSE:PBH) closed its acquisition of the Breathe Right brand for $1.045 billion.

Parsons (NYSE:PSN) secured design and construction oversight contracts for the estimated $1.1–$1.4 billion John A. Blatnik Bridge replacement project.

InterDigital (NASDAQ:IDCC) secured a patent infringement injunction against Disney (NYSE:DIS) across 11 European Union countries for its video technology.

ITT (NYSE:ITT) signed a definitive agreement to acquire Aerospace Contacts LLC for a purchase price of $31 million.

Space Exploration Technologies (NASDAQ:SPCX) and Anysphere (“Cursor”) announced they have entered into an agreement and plan of merger.

Olin (NYSE:OLN) and Huntsman (NYSE:HUN) agreed to an all-stock merger to form a $12.5 billion chemical company.

Beam Global (NASDAQ:BEEM) secured European Patent EP 4 348 756 B1 for its passive battery thermal management technology.